Orbimed Advisors LLC Dice Therapeutics, Inc. Call Options Transaction History
Orbimed Advisors LLC
- $4.24 Billion
- Q3 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding DICE
# of Institutions
3Shares Held
17.7KCall Options Held
13KPut Options Held
0About DICE Therapeutics, Inc.
- Ticker DICE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,430,000
- Description
- DICE Therapeutics, Inc., a biopharmaceutical company, builds various oral therapeutic candidates to treat chronic diseases in immunology and other therapeutic areas. Its platform DELSCAPE, is designed to discover selective oral small molecules to modulate protein-protein interactions (PPIs) as effectively as systemic biologics. The company's lea...